Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
|Articles|August 10, 2015
Dr. Jessica Ryan on the Role of Nurses in Extreme Oncoplasty
Author(s)Jessica Ryan, MD
Jessica Ryan, MD, breast surgeon, Elliot Breast Health Center, Manchester, New Hampshire, discusses the role of oncology nurses in extreme oncoplasty.
Advertisement
Jessica Ryan, MD, breast surgeon, Elliot Breast Health Center, Manchester, New Hampshire, discusses the role of oncology nurses in extreme oncoplasty.
Advertisement
Related to this article
Brianne Whitley, CNP, of Dana-Farber, shares strategies for hot flashes, sexual health, survivorship planning, and clinical trial access for men.
Dana-Farber's Brianne Whitley, CNP, details red-flag symptoms, ER-positive biology, and why every man with breast cancer needs a genetic referral.
Erika Hamilton, MD, breaks down liver monitoring, diarrhea, creatinine shifts, and oral adherence with maintenance tucatinib in HER2+ MBC.
ABUS matched handheld ultrasound on cancer detection in women with dense breasts while lowering recall and short-interval follow-up rates.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
Two Winship nurses explain how to talk with breast cancer survivors about GLP-1 receptor agonists, from endocrine therapy to access barriers.
For MBC Awareness Day, an NP and a former ICU nurse living with metastatic breast cancer discuss repeat education, biomarker testing, and support.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Sunvozertinib Now Available in US for Pretreated EGFR Exon 20+ NSCLC
2
FDA Grants Traditional Approval to Pembrolizumab in TMB-H Solid Tumors
3
Where Oncology and Transplant Care Intersect: A Nurse’s Perspective
4
Male Breast Cancer: Warning Signs, Biology, and Genetic Testing
5